Cytokines as genetic modifying factors in immune and inflammatory diseases

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue SUPPL. 1, 1996, Pages 129-132

  Cox, A ^a   Duff, G W ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Cytokine; Haplotype; Interleukin; MHC; Tumour necrosis factor

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; CONFERENCE PAPER; HAPLOTYPE; HEREDITY; HUMAN; INFLAMMATION;

EID: 0029916113     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.1996.9.s1.129     Document Type: Conference Paper

References (28)

1. Duff GW. Autoimmune disease and cytokine-gene polymorphisms. Rheumatology in Europe 1994; 23. 100-103
2. 2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705-716.
3. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652.
4. Nicklin MJH, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1alpha, interleukin-1beta, and interleukin-1 receptor antagonist genes Genomics 1993; 19: 382-384.
5. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1alpha polymorphism. Arthritis and Rheumatism 1995, 38: 221-228.
6. Blakemore AIF, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 111-115.
7. Clay FE, Tarlow JK, Cork MJ, Cox A, Nicklin MJH, Duff GW. Novel interleukin one receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment Human Genet (in press).
8. Danis VA, Millington M, Hyland VJ, Grennan D Cytokine production by normal human monocytes. intersubject variation and relationship to an IL-1 receptor antagonist (IL-RA) gene polymorphism Clin Exp Immunol 1995; 99 303-310.
9. Mandrup-Poulsen T, Pociot F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems LL, Dinarello C, Nerup J Monokine antagonism is reduced in patients with IDDM. Diabetes 1994, 43. 1242-1247
10. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornelis F, Barnett AH, Bain SC, Todd JA. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995; 9 80-85.
11. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taq I polymorphism in the human interleukin-1beta (IL-1beta) gene correlates with IL-1beta secretion in vitro Eur J Clin Invest 1992; 22: 396-402.
12. Pociot F, Nerup J. A chromosome 2 susceptibility marker in familial IDDM: the IL-1 receptor antagonist. Diabetologia 1993; 36 (S1): A17.
13. Blakemore AIF, Cox A, Gonzalez AM, Tarlow JK, Hughes M, Wilson RM, Ward JD, Duff GW. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996, 97. 369-374.
14. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNFalpha) gene detectable by Nco I restriction of PCR product. Hum Mol Genet 1992; 1. 353.
15. Wilson AG, de Vries N, Pociot F, di Giovine FS, van de Putte LBA, Duff GW An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with the HLA A1, B8 and DR3 alleles. J Exp Med 1993; 177: 577-560.
16. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-231.
17. Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor-alpha promoter region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 3050-3053.
18. Cox A, Gonzalez AM, Wison AG, Wilson RM, Ward JD, Artlett CM, Welsh K, Duff GW. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 1994; 37: 500-503
19. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQalpha/beta heterodimer. J Exp Med 1989; 169 345-350.
20. Mansfield JC, Holden H, Wilson AG, Holdsworth CD, Duff GW. Coeliac disease associates with a polymorphism in the promoter region of the TNF alpha gene and further defines the coeliac haplotype. Gut 1993; 34 S23.
21. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes H, Steinkasserer A, Duff GW. Polymorphisms in the human IL-1receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat Hum Genet 1993; 91: 403-404.
22. van den Weldon PA, Reitsma PH. Amino acid dimorphism in IL1A is detectable by PCR amplification Hum Molec Genet 1993; 2: 1753
23. Mansfeld JC, Holden H, Tarlow JK, di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastoenterology 1994; 106: 637-642.
24. Tarlow JK, Clay FE, Cork MJ, Blakemore AIR, McDonagh AJG, Messenger AG, Duff GW. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene J Invest Dermatol 1994; 103: 387-390.
25. Clay FE, Cork MJ, Tarlow JK, Blakemore AIF, Harrington CI, Lewis F, Duff GW. Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerosis. Hum Genet 1994; 94: 407-410.
26. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis and Rheumatism 1994; 37: 1380-1385.
27. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LBA, Emery P, Duff GW. A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur J Immunol 1994, 24 191-195.
28. Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW Comparative genetic association of human leukocyte antigen class II and tumour necrosis factor-alpha with dermatitis herpetiformis. J Invest Derm 1995; 104: 856-858.